Abstract 12
Category: Clinical

At the end of the session, participants will be able to:

  1. Recognize the histological and molecular features of infant-type hemispheric glioma (IHG).
  2. Differentiate IHG from desmoplastic infantile astrocytoma /ganglioglioma.
  3. Differentiate IHG from other high-grade gliomas based on histological and molecular criteria.

COI Disclosure:

None to disclose.

Presenter

I am a neuropathologist and pediatric pathologist

Authors

Murad Alturkustani¹
1 Department of Pathology, King Abdulaziz University, Jeddah, Saudi Arabia

    Target Audience:

    Pathologists, Residents

    CanMEDS:
    Medical Expert (the integrating role)

    Infant-type hemispheric glioma is mostly relatively well-demarcated tumor and not diffusely infiltrative

    Abstract

    Background: IHG has been identified as a distinct entity with unique methylation patterns and gene fusions, presenting a better prognosis than other pediatric high-grade gliomas. The current WHO classification presents discrepancies regarding the tumor’s circumscription, necessitating further investigation.

    Methods: The Children’s Brain Tumor Network dataset of 1029 samples was accessed, selecting tumors from patients aged 0-4 years, resulting in 191 gliomas, glioneuronal tumors, and ependymomas. Methylation profiles were analyzed using the Heidelberg v12.5 and v12.8 classifiers. Cases were selected based on diagnoses of IHG, desmoplastic infantile astrocytoma /ganglioglioma (DIA/G), or high-grade gliomas with available methylation class. Morphological assessments focused on tumor circumscription, low-grade areas, glial differentiation, and high-grade features.

    Results: The final cohort included 12 cases: 4 with an initial diagnosis of DIA/G, and 8 with an initial diagnosis of high-grade astrocytoma (6 diagnosed as IHG). All IHG cases were infantile tumors, while DIA/G cases were in older children. Both IHG and DIA/G were well-circumscribed, whereas the case with diffuse infiltration was classified as diffuse pediatric high-grade glioma. The 4 DIA/G cases were heterogeneous, with only one showing the methylation profile of DIG. One DIA/G case was reclassified as IHG. The remaining six IHG cases were initially diagnosed as high-grade astrocytoma.

    Conclusion: IHG is predominantly a well-circumscribed tumor, contrasting with the diffuse infiltration characteristic of other pediatric high-grade gliomas. Recognizing these histological features, along with molecular profiling, is crucial for accurate diagnosis and management.